Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

INTRODUCTION AND OBJECTIVES: Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Otero, Diego, López-Pais, Javier, Cacho-Antonio, Carla Eugenia, Antúnez-Muiños, Pablo José, González-Ferrero, Teba, Pérez-Poza, Marta, Otero-García, Óscar, Díaz-Fernández, Brais, Bastos-Fernández, María, Bouzas-Cruz, Noelia, Sanmartín-Pena, Xoan Carlos, Varela-Román, Alfonso, Portela-Romero, Manuel, Valdés-Cuadrado, Luis, Pose-Reino, Antonio, González-Juanatey, José Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274611/
https://www.ncbi.nlm.nih.gov/pubmed/32600991
http://dx.doi.org/10.1016/j.rec.2020.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274611/
https://www.ncbi.nlm.nih.gov/pubmed/32600991
http://dx.doi.org/10.1016/j.rec.2020.05.018

Ejemplares similares